Ado Muhammad, MBBS MSc DPM FRCP FFPM FFPH MGPH MBA
A Nigerian-born British physician, Dr Muhammad obtained his medical qualification from Ahmadu Bello University, Zaria-Nigeria in 1990. He practiced mainly orthopaedic surgery for many years in public and private medical practice in Nigeria before moving to the UK. He was trained at the Institute of Orthopaedics, University College London and Epsom General Hospital.
Dr Muhammad started a career in the pharmaceutical industry in 2002. He joined early phase Charterhouse Clinical Research and Richmond Pharmacology both in London. He worked briefly for PPD Inc before joining GW Pharmaceuticals, a UK pharmaceutical company specialized in research and development of innovative cannabinoids medicine.
He worked as the medical director of GW for 6 years during which he supported several cannabinoid clinical research programmes in the company and helped bring the first cannabinoid medicine in the world (Sativex) to the market in 2010.
Dr Muhammad was trained in pharmaceutical medicine at the UK’s Faculty of Pharmaceutical Medicine (FPM) of the Royal College of Physicians as well as at the University of Wales in Cardiff. He is honoured with the fellowships of both the FPM (the highest professional honour and recognition in pharmaceutical medicine specialty and the pharmaceutical industry) and of the Royal College of Physicians of London. His areas of expertise are in safety and pharmacovigilance of medicinal products.
So far, he has worked for many global pharmaceutical companies including InMed Pharmaceuticals (Vancouver, Canada – another cannabis medicines research and development company), Ipsen, AstraZeneca, UCB, IO Biotech and Cybin in various capacities including as a chief medical officer, vice-president and senior global medical director helping these companies to develop and register several neurology, oncology and other products globally. He has also executed pharmaceutical research projects and consulted for regulatory authorities, helping to draft guidelines, conduct training and inspections under his company, Pharmedas. Pharmedas is present in Nigeria, UK and the USA.
Dr Muhammad hold a specialist MBA in pharmaceutical industry management and is a current board member of the FPM. Apart from Pharmaceutical Medicine practice, Dr Muhammad is a keen global health enthusiast with special interests in the areas of drug development for neglected and rare diseases, planetary, environmental and social determinants of health. He acquired a postgraduate degree in global public health from Queen Mary’s University of London and is a fellow of the UK’s Faculty of Public Health. He supported several projects in the UK’s Public Health department.
Dr Muhammad has attended many courses and educational programmes across the globe and is a member of many professional bodies.